运用 Anderson-Gill 计数过程模型评价纤维蛋白原与非小细胞肺癌总体生存的关联*

向伊冉 ,  海良 ,  夏夕然 ,  杨青 ,  肖媛媛

中国卫生统计 ›› 2026, Vol. 43 ›› Issue (3) : 328 -332.

PDF (730KB)
中国卫生统计 ›› 2026, Vol. 43 ›› Issue (3) : 328 -332. DOI: 10.11783/j.issn.1002-3674.2026.03.002
论著

运用 Anderson-Gill 计数过程模型评价纤维蛋白原与非小细胞肺癌总体生存的关联*

作者信息 +

The Application of Anderson-Gill Counting Process Model in Evaluating the Association between Fibrinogen and the Overall Survival of Non Small Cell Lung Cancer

Author information +
文章历史 +
PDF (746K)

摘要

目的 通过构建Anderson-Gill(AG)计数过程模型,探索动态变化的纤维蛋白原对非小细胞肺癌(non small cell lung cancer,NSCLC)患者预后的潜在意义,为非小细胞肺癌患者的临床治疗提供重要的参考依据。方法 本研究回顾性收集2013年1月至2018年12月在昆明医科大学第三附属医院经病理检查确诊为非小细胞肺癌的748例患者信息。采用Kaplan-Meier法绘制生存曲线,构建AG模型估计生存期内纤维蛋白原与非小细胞肺癌患者总体生存的关联,利用限制性立方样条函数拟合两者的剂量-反应关系。结果 生存期内共有530例患者发生死亡,多因素AG模型结果提示纤维蛋白原是非小细胞肺癌患者总体生存的独立预后因素,其中较高的纤维蛋白原水平提示较差的总体生存(HR=1.35,P<0.05)。同时纤维蛋白原水平与非小细胞肺癌患者总体生存未呈现出显著的非线性关系(P-Nonlinear=0.68>0.05)。结论 较高的纤维蛋白原水平是非小细胞肺癌患者总体生存的危险因素,AG模型是估计时依性变量与生存结局关联的理想选择。

Abstract

Objective To explore the significance of dynamic fibrinogen in the overall survival of patients with non small cell lung cancer (NSCLC) by using the Anderson-Gill(AG) counting process model,so as to provide important scientific evidence in guiding the clinical treatment of NSCLC patients.Methods This study retrospectively collected the information of 748 NSCLC patients diagnosed by histological examination in the Third Affiliated Hospital of Kunming Medical University from January 2013 to December 2018. Survival curves were plotted using the Kaplan-Meier method. The association between fibrinogen and overall survival of NSCLC was evaluated by AG models. Restricted cubic spline was further used to fit the dose-response relationship between fibrinogen and the overall survival.Results During the follow-up period,530 patients died. The multivariate AG model identified a significant association between dynamic fibrinogen and overall survival of NSCLC,with higher fibrinogen levels associated with worse overall survival (HR=1. 35,P<0. 05). Additionally,the RCS results showed that there was no significant non-linear relationship between serum fibrinogen and overall survival in patients with NSCLC in the AG model(P-Nonlinear=0. 68>0. 05).Conclusion Higher fibrinogen level is a risk factor for overall survival in NSCLC patients,and AG model can be an ideal choice in estimating the associations between time-varying variables and survival outcomes.

关键词

纤维蛋白原 / 非小细胞肺癌 / 总体生存 / Anderson-Gill计数过程模型

Key words

Fibrinogen / Non small cell lung cancer / Overall survival / Anderson-Gill counting process model

引用本文

引用格式 ▾
向伊冉,海良,夏夕然,杨青,肖媛媛. 运用 Anderson-Gill 计数过程模型评价纤维蛋白原与非小细胞肺癌总体生存的关联*[J]. 中国卫生统计, 2026, 43(3): 328-332 DOI:10.11783/j.issn.1002-3674.2026.03.002

登录浏览全文

4963

注册一个新账户 忘记密码

参考文献

[1]

张雪燕,马晓天,侯子茜,等. 胸腔镜非小细胞肺癌术后患者肺部并发症风险预测模型的建立[J].中国卫生统计, 2024, 41(1): 102-105.

[2]

李艳华,魏素菊,王俊艳,等. 非小细胞肺癌患者凝血功能异常的相关因素与预后分析[J].中国肺癌杂志,2014,17(11): 789.

[3]

Hoffman PC,Mauer AM,Vokes EE. Lung cancer [J].Lancet,2000,355(9202): 479-485.

[4]

PDQ Adult Treatment Editorial Board. Non—Small Cell Lung Cancer Treatment (PDQ®): Health Professional Version [EB/OL]. (2025—05—07)[2025—11—23].https://www.ncbi.nlm.nih.gov/books/NBK65865/.

[5]

Vasudevan S, Krishna V, Mehta A. Lung cancer in non—smokers: clinicopathological and survival differences from smokers [J].Cureus,2022,14(12): e32417.

[6]

Sheikh M,Mukeriya A,Shangina O,et al. Postdiagnosis smoking cessation and reduced risk for lung cancer progression and mortality: a prospective cohort study [J].Annals of Internal Medicine,2021,174(9): 1232-1239.

[7]

Torres—Roman JS,Valcarcel B,Martinez—Herrera JF,et al. Mortality Trends for Lung Cancer and Smoking Prevalence In Peru [J].Asian Pacific Journal of Cancer Prevention: APJCP,2022,23(2): 435.

[8]

Jones CC, Mercaldo SF, Blume JD, et al. Racial disparities in lung cancer survival: the contribution of stage,treatment,and ancestry [J].Journal of Thoracic Oncology,2018,13(10): 1464-1473.

[9]

Wei S, Tian J, Song X, et al. Causes of death and competing risk analysis of the associated factors for non—small cell lung cancer using the Surveillance,Epidemiology,and End Results database[J].Journal of Cancer Research and Clinical Oncology, 2018, 144(1): 145-155.

[10]

Wang W, Dou S, Dong W, et al. Impact of COPD on prognosis of lung cancer: from a perspective on disease heterogeneity [J].International Journal of Chronic Obstructive Pulmonary Disease,2018,13: 3767-3776.

[11]

Qi Y, Fu J. Research on the coagulation function changes in non small cell lung cancer patients and analysis of their correlation with metastasis and survival [J].J Buon,2017,22(2): 462-467.

[12]

燕启田. D—二聚体、纤维蛋白原水平与肝癌根治术后患者预后的相关性[J].中国民康医学,2023,35(17): 127-129.

[13]

庞杏峰. 回顾性分析凝血指标PT、FIB在原发性肝癌中的变化及其预后价值[D].南宁:广西医科大学,2022.

[14]

Zhang K,Xu Y,Tan S,et al. The association between plasma fibrinogen levels and lung cancer: a meta—analysis [J].Journal of Thoracic Disease,2019,11(11): 4492.

[15]

Zhang Y,Cao J,Deng Y,et al. Pretreatment plasma fibrinogen level as a prognostic biomarker for patients with lung cancer [J].Clinics,2020,75: e993.

[16]

Kim KH, Park TY, Lee JY, et al. Prognostic significance of initial platelet counts and fibrinogen level in advanced non—small cell lung cancer [J].Journal of Korean Medical Science,2014,29(4): 507.

[17]

Jiang HG,Li J,Shi SB,et al. Value of fibrinogen and D—dimer in predicting recurrence and metastasis after radical surgery for non—small cell lung cancer [J].Medical Oncology,2014,31: 1-9.

[18]

Mitsui S, Tanaka Y, Doi T, et al. Prognostic value of preoperative plasma fibrinogen levels in resected stage I non—small cell lung cancer [J].Thoracic Cancer,2022,13(10): 1490-1495.

[19]

Fay MP,Graubard BI,Freedman LS,et al. Conditional logistic regression with sandwich estimators: application to a meta—analysis [J].Biometrics,1998,54(1):195-208.

[20]

Harrell FE. Regression modeling strategies: with applications to linear models,logistic regression,and survival analysis [M]. New York: Springer,2001.

[21]

Palumbo JS, Talmage KE, Massari JV, et al. Platelets and fibrin (ogen) increase metastatic potential by impeding natural killer cell—mediated elimination of tumor cells [J].Blood, 2005, 105(1): 178-185.

[22]

Xiao Y,Xie H,Xie Z,et al. Kinetics of postdiagnosis platelet count with overall survival of pancreatic cancer: a counting process approach [J].Cancer Medicine,2016,5(5): 881-887.

[23]

肖媛媛,许传志,赵耐青. 常用生存分析模型及其对时依性协变量效应的估计方法[J].中国卫生统计,2016,33(3): 543-547.

基金资助

*云南省基础研究计划面上项目(202201AT070200)

云南省教育厅科技创新团队、昆明医科大学一流学科团队(2024XKTDTS16)

AI Summary AI Mindmap
PDF (730KB)

0

访问

0

被引

详细

导航
相关文章

AI思维导图

/

〈 〉